297 related articles for article (PubMed ID: 27987061)
1. Management of aggressive growth hormone secreting pituitary adenomas.
Donoho DA; Bose N; Zada G; Carmichael JD
Pituitary; 2017 Feb; 20(1):169-178. PubMed ID: 27987061
[TBL] [Abstract][Full Text] [Related]
2. Management of growth hormone-secreting pituitary adenomas causing acromegaly: a practical review of surgical and multimodal management strategies for neurosurgeons.
Cheok SK; Carmichael JD; Zada G
J Neurosurg; 2024 May; 140(5):1285-1294. PubMed ID: 37948697
[TBL] [Abstract][Full Text] [Related]
3. Expression of the long non-coding RNA H19 and MALAT-1 in growth hormone-secreting pituitary adenomas and its relationship to tumor behavior.
Lu T; Yu C; Ni H; Liang W; Yan H; Jin W
Int J Dev Neurosci; 2018 Jun; 67():46-50. PubMed ID: 29604339
[TBL] [Abstract][Full Text] [Related]
4. The role of stereotactic radiosurgery in the multimodal management of growth hormone-secreting pituitary adenomas.
Stapleton CJ; Liu CY; Weiss MH
Neurosurg Focus; 2010 Oct; 29(4):E11. PubMed ID: 20887121
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas.
Pangal DJ; Wishart D; Shiroishi MS; Ruzevick J; Carmichael JD; Zada G
Pituitary; 2022 Jun; 25(3):480-485. PubMed ID: 35334028
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases.
Chen M; Duan L; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
Pituitary; 2023 Dec; 26(6):675-685. PubMed ID: 37847430
[TBL] [Abstract][Full Text] [Related]
7. Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives.
Cuny T; Barlier A; Feelders R; Weryha G; Hofland LJ; Ferone D; Gatto F
Ann Endocrinol (Paris); 2015 Feb; 76(1):43-58. PubMed ID: 25556152
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
9. Radiation treatment strategies for acromegaly.
Rowland NC; Aghi MK
Neurosurg Focus; 2010 Oct; 29(4):E12. PubMed ID: 20887122
[TBL] [Abstract][Full Text] [Related]
10. Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors.
Shimon I; Jallad RS; Fleseriu M; Yedinak CG; Greenman Y; Bronstein MD
Eur J Endocrinol; 2015 Jun; 172(6):707-13. PubMed ID: 25792375
[TBL] [Abstract][Full Text] [Related]
11. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
Campbell PG; Kenning E; Andrews DW; Yadla S; Rosen M; Evans JJ
Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP; Mannaa RH; Mubita L; Anand VK; Kennedy JW; Dehdashti AR; Schwartz TH
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[TBL] [Abstract][Full Text] [Related]
15. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H; Fukuhara N; Horiguchi K; Yamada S
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[TBL] [Abstract][Full Text] [Related]
16. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission.
Pollock BE; Jacob JT; Brown PD; Nippoldt TB
J Neurosurg; 2007 May; 106(5):833-8. PubMed ID: 17542527
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
Bellut D; Hlavica M; Schmid C; Bernays RL
Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
[TBL] [Abstract][Full Text] [Related]
18. Novel use of endogenous GH-measurement directly after transsphenoidal microsurgery in acromegaly treated with pegvisomant.
Lüdecke DK; Crock PA; Bidlingmaier M; Schuppert F
Exp Clin Endocrinol Diabetes; 2013 Aug; 121(8):509-12. PubMed ID: 23765756
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone-secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog (90)Y-DOTATATE: case report.
Waligórska-Stachura J; Gut P; Sawicka-Gutaj N; Liebert W; Gryczyńska M; Baszko-Błaszyk D; Blanco-Gangoo AR; Ruchała M
J Neurosurg; 2016 Aug; 125(2):346-9. PubMed ID: 26636388
[TBL] [Abstract][Full Text] [Related]
20. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
Schwyzer L; Starke RM; Jane JA; Oldfield EH
J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]